Literature DB >> 24184685

The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors.

Rachel E J Roach1, Willem M Lijfering, Astrid van Hylckama Vlieg, Frans M Helmerhorst, Frits R Rosendaal, Suzanne C Cannegieter.   

Abstract

Superficial vein thrombosis (SVT) increases the risk of venous thrombosis fourfold to sixfold. As most individuals with SVT do not develop venous thrombosis, additional risk factors may explain the risk of developing a venous thrombosis. In the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis study, we assessed the risk of venous thrombosis in individuals with previous SVT and a mild thrombotic risk factor (smoking or overweight/obesity), a strong risk factor (surgery, hospitalization, plaster cast immobilization, or malignancy), or a reproductive factor in women (oral contraception, postmenopausal hormone therapy, or pregnancy/puerperium). Individuals with previous SVT alone had a 5.5-fold (95% confidence interval [CI], 4.4-6.8) increased risk of venous thrombosis. This was 9.3 (95% CI, 7.2-12.1) combined with a mild thrombotic risk factor, 31.4 (95% CI, 14.6-67.5) with a strong risk factor, and 34.9 (95% CI, 19.1-63.8) in women with a reproductive risk factor. The highest separate risk estimates were found for SVT with surgery (42.5; 95% CI, 10.2-177.6), hospitalization (49.8; 95% CI, 11.9-209.2), or oral contraception (43.0; 95% CI, 15.5-119.3 in women). In conclusion, the risk of venous thrombosis is markedly increased in individuals with previous SVT who have an acquired thrombotic risk factor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24184685     DOI: 10.1182/blood-2013-07-518159

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.

Authors:  Sara Calzavarini; Raja Prince-Eladnani; François Saller; Luca Bologna; Laurent Burnier; Anne C Brisset; Claudia Quarroz; Maria Desiré Reina Caro; Vladimir Ermolayev; Yasuhiro Matsumura; José A Fernández; Tilman M Hackeng; John H Griffin; Anne Angelillo-Scherrer
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

Review 2.  Nocturia through the menopausal transition and beyond: a narrative review.

Authors:  Kim Pauwaert; An-Sofie Goessaert; Lynn Ghijselings; Thomas F Monaghan; Herman Depypere; Karel Everaert
Journal:  Int Urogynecol J       Date:  2021-01-13       Impact factor: 2.894

Review 3.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

4.  Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies.

Authors:  Michel K Barsoum; Kevin P Cohoon; Véronique L Roger; Ramila A Mehta; David O Hodge; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2014-07-05       Impact factor: 3.944

5.  Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.

Authors:  Bethany Samuelson; Alan S Go; Sue Hee Sung; Dongjie Fan; Margaret C Fang
Journal:  J Hosp Med       Date:  2016-02-01       Impact factor: 2.960

6.  Superficial venous thrombosis of the upper limb presenting to a chiropractic clinic: a case report.

Authors:  Paul Mastragostino; Chadwick Chung
Journal:  J Can Chiropr Assoc       Date:  2020-04

Review 7.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

8.  Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.

Authors:  Geert-Jan Geersing; Selma Cazemier; Frans Rutten; David A Fitzmaurice; Arno W Hoes
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

9.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.